Analyst Ratings for Ligand Pharma (LGND)
LGND Rating Summary
LGND Price Target Summary
- Highest: $144.00 (H.C. Wainwright)
- Lowest: $65.00 (JPMorgan)
- Average: $104.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$104.00 (+77%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
Rating Score: 6 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/14/2021 | Stephens » Updated 5/16/2022 |
Jacob Johnson | New Coverage | Overweight (N/A) |
130.00 (153.00) |
147.00 (58.75) |
-60.03% | Details |
10/6/2020 | Barclays » Updated 7/25/2023 |
Balaji Prasad | New Coverage | Overweight (N/A) |
110.00 (120.00) |
97.15 (58.75) |
-39.53% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |